Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20092
20101
20122
20132
20181
20191
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Astex Pharmaceuticals, Inc.1
AstraZeneca1
BeiGene1
Boehringer Ingelheim1
CatalYm GmbH1
Children's Cancer and Leukaemia Group1
Exelixis1
Fore Biotherapeutics1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular15
Liver Neoplasms3
Biliary Tract Neoplasms2
Breast Neoplasms2
Neoplasms2
Ovarian Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Cholangiocarcinoma1
Colorectal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.